{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:41Z","timestamp":1787760641995,"version":"build-2784847793"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jtct.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T16:13:02Z","timestamp":1673712782000},"page":"222-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-2869","authenticated-orcid":false,"given":"Dionysios","family":"Neofytos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-079X","authenticated-orcid":false,"given":"Genovefa A.","family":"Papanicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-314X","authenticated-orcid":false,"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.01.011_bib0002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciy150","volume":"67","author":"Cesaro","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtct.2020.10.004","article-title":"American Society for Transplantation and Cellular Therapy infectious disease guidelines: preface to the series","volume":"27","author":"Carpenter","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"14 suppl 13","key":"10.1016\/j.jtct.2023.01.011_bib0003","first-page":"9","article-title":"Invasive Candida infections: the changing epidemiology","volume":"18","author":"Marr","year":"2004","journal-title":"Oncology (Williston Park)."},{"key":"10.1016\/j.jtct.2023.01.011_bib0004","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the Prospective Antifungal Therapy Alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1703252","article-title":"Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome","volume":"28","author":"Safdar","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.01.011_bib0006","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1128\/JCM.00131-14","article-title":"Epidemiology of Candida kefyr in patients with hematologic malignancies","volume":"52","author":"Dufresne","year":"2014","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.jtct.2023.01.011_bib0007","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/infdis\/jix597","article-title":"The Candida auris alert: facts and perspectives","volume":"217","author":"Lamoth","year":"2018","journal-title":"J Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmi.2017.08.016","article-title":"Acute disseminated candidiasis with skin lesions: a systematic review","volume":"24","author":"Guarana","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.jtct.2023.01.011_bib0009","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1439-0507.2012.02182.x","article-title":"New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis","volume":"55","author":"Rammaert","year":"2012","journal-title":"Mycoses."},{"key":"10.1016\/j.jtct.2023.01.011_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0732-8893(93)90020-8","article-title":"Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection","volume":"17","author":"Berenguer","year":"1993","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/JCM.42.1.115-118.2004","article-title":"Direct comparison of the BACTEC 9240 and BacT\/ALERT 3D automated blood culture systems for Candida growth detection","volume":"42","author":"Horvath","year":"2004","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.jtct.2023.01.011_bib0012","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/JCM.05742-11","article-title":"Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories","volume":"50","author":"Spanu","year":"2012","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.jtct.2023.01.011_bib0013","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10096-016-2781-y","article-title":"Comparison of BACTEC\u2122 blood culture media for the detection of fungemia","volume":"36","author":"Datcu","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0014","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1469-0691.2009.02931.x","article-title":"Detection of candidaemia in patients with and without underlying haematological disease","volume":"16","author":"Arendrup","year":"2010","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.jtct.2023.01.011_bib0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0891-5520(05)70128-8","article-title":"Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis","volume":"14","author":"Kontoyiannis","year":"2000","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.jtct.2023.01.011_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0017","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0018","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","article-title":"Reappraisal of the serum (1\u21923)-beta-D-glucan assay for the diagnosis of invasive fungal infections\u2014a study based on autopsy cases from 6 years","volume":"46","author":"Obayashi","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0019","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u00df-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0020","first-page":"e14399","article-title":"Prospective evaluation of the Fungitell\u00ae(1\u21923) beta-D-glucan assay as a diagnostic tool for invasive fungal disease in pediatric allogeneic hematopoietic cell transplantation: a report from the Children's Oncology Group","author":"Otto","year":"202327","journal-title":"Pediatr Transplant."},{"issue":"suppl 1)","key":"10.1016\/j.jtct.2023.01.011_bib0021","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1\u21923)-beta-D-glucan in the diagnosis of invasive aspergillosis","volume":"47","author":"Marty","year":"2009","journal-title":"Med Mycol."},{"key":"10.1016\/j.jtct.2023.01.011_bib0022","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/ciab1028","article-title":"High false-positive rate of (1,3)-\u00df-D-glucan in onco-hematological patients receiving immunoglobulins and therapeutic antibodies","volume":"75","author":"Tschopp","year":"2022","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0023","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0024","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jtct.2023.01.011_bib0025","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Riboli","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jtct.2023.01.011_bib0026","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis."},{"issue":"11","key":"10.1016\/j.jtct.2023.01.011_bib0027","first-page":"994","article-title":"Comparative effectiveness of echinocandins vs triazoles or amphotericin B formulations as initial directed therapy for invasive candidiasis in children and adolescents","volume":"10","author":"Fisher","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jtct.2023.01.011_bib0028","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0029","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/AAC.01144-13","article-title":"Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure","volume":"57","author":"Lewis","year":"2013","journal-title":"Antimicrob Agents Che mother."},{"key":"10.1016\/j.jtct.2023.01.011_bib0030","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/jac\/dkz277","article-title":"MSG-10: a phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis","volume":"74","author":"Spec","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.jtct.2023.01.011_bib0031","article-title":"Ibrexafungerp: a novel oral triterpenoid antifungal in development for the treatment of Candida auris infections","volume":"9:539","author":"Ghannoum","year":"2020","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.jtct.2023.01.011_bib0032","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1093\/cid\/ciaa1380","article-title":"Rezafungin versus caspofungin in a phase 2, randomized, double-blind study for the treatment of candidemia and invasive candidiasis: the STRIVE trial","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0033","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/cid\/cix744","article-title":"Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast","volume":"66","author":"Tsay","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0034","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jtct.2023.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0036","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9343(01)01127-5","article-title":"Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy","volume":"112","author":"MacMillan","year":"2002","journal-title":"Am J Med."},{"key":"10.1016\/j.jtct.2023.01.011_bib0037","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.01.011_bib0038","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0039","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbmt.2007.03.005","article-title":"Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation","volume":"13","author":"Upton","year":"2007","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.01.011_bib0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jtct.2023.01.011_bib0041","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.01.011_bib0042","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.01.011_bib0043","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/528690","article-title":"A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults","volume":"46","author":"McMullan","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0044","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.jtct.2023.01.011_bib0045","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0046","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cix1095","article-title":"Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida Panel","volume":"66","author":"Clancy","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0047","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cid\/ciab928","article-title":"Multicenter prospective study of biomarkers for diagnosis of invasive candidiasis in children and adolescents","volume":"75","author":"Fisher","year":"2022","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0048","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.01.011_bib0049","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cncr.20710","article-title":"Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections","volume":"101","author":"Safdar","year":"2004","journal-title":"Cancer."},{"key":"10.1016\/j.jtct.2023.01.011_bib0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.01.011_bib0051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkm169","article-title":"Caspofungin for the treatment of less common forms of invasive candidiasis","volume":"60","author":"Cornely","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.jtct.2023.01.011_bib0052","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0053","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jtct.2023.01.011_bib0054","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.2010.64","article-title":"Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma","volume":"88","author":"Jang","year":"2010","journal-title":"Clin Pharmacol Ther."},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.01.011_bib0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.jtct.2023.01.011_bib0056","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive Candida infections: the ACTIVE trial","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin Infect Dis."}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:20:25Z","timestamp":1721683225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2666636723000350"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}